Islam Sadek

Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

Francisco Cervantes, David M. Ross, Atanas Radinoff et al. · Leukemia · 2021 · 66 citations · Full text

Medicine, Hematology, Pharmacology +9

MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria

Mohamed A. Yassin, Alì Taher, Vikram Mathews et al. · Cancer Medicine · 2020 · 63 citations · Full text

Medicine, Hematology, Internal Medicine +17

Amiodarone-induced epididymitis: report of a new case and literature review of 12 cases.

Islam Sadek, Pierre Biron, Teresa Kuś · PubMed · 1993 · 27 citations

Veterinary Medicine, Internal Medicine, Pharmacology +10

Treatment patterns and outcomes in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis

Eytan M. Stein, Gaetano Bonifacio, Dominick Latrémouille-Viau et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2021 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +13

Sabatolimab (MBG453) Combination Treatment Regimens for Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS): The MDS Studies in the Stimulus Immuno-Myeloid Clinical Trial Program

Amer M. Zeidan, Aref Al‐Kali, Uma Borate et al. · Blood · 2021 · 12 citations

Medicine, Oncology, Pharmacotherapy +10